WO1999032032A1 - Non-invasive device for electromyographic measurements - Google Patents
Non-invasive device for electromyographic measurements Download PDFInfo
- Publication number
- WO1999032032A1 WO1999032032A1 PCT/FR1998/002837 FR9802837W WO9932032A1 WO 1999032032 A1 WO1999032032 A1 WO 1999032032A1 FR 9802837 W FR9802837 W FR 9802837W WO 9932032 A1 WO9932032 A1 WO 9932032A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrodes
- signals
- housing
- groups
- amplification
- Prior art date
Links
- 238000005259 measurement Methods 0.000 title claims abstract description 21
- 238000001914 filtration Methods 0.000 claims abstract description 22
- 230000003595 spectral effect Effects 0.000 claims abstract description 14
- 238000012545 processing Methods 0.000 claims abstract description 11
- 238000001514 detection method Methods 0.000 claims description 20
- 230000036982 action potential Effects 0.000 claims description 15
- 230000003387 muscular Effects 0.000 claims description 14
- 230000003321 amplification Effects 0.000 claims description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 13
- 238000010183 spectrum analysis Methods 0.000 claims description 4
- 210000003205 muscle Anatomy 0.000 description 14
- 238000000034 method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000002567 electromyography Methods 0.000 description 6
- 230000007170 pathology Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 4
- 210000001087 myotubule Anatomy 0.000 description 4
- 230000002232 neuromuscular Effects 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000003183 myoelectrical effect Effects 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 210000000715 neuromuscular junction Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000011889 copper foil Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- 230000003483 hypokinetic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229950007002 phosphocreatine Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/296—Bioelectric electrodes therefor specially adapted for particular uses for electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
Definitions
- the invention relates to the non-invasive evaluation of the neuromuscular system of living beings by surface electromyography.
- the measurement is carried out by receiving signals at the electrodes resulting from a muscular contraction caused either voluntarily, or by mechanical or electrical stimulation.
- Surface electromyography consists of detecting, record and process the myoelectric signal received, the precursor of the muscle contraction obtained.
- This technique aims to identify certain neurological or muscular diseases whose physiological characteristics can result in the deviation of certain signal parameters: amplitudes, signal frequencies or propagation velocities of muscular action potentials.
- certain pathologies are characterized by preferential degenerations of one type of fiber compared to another.
- Duchenne muscular dystrophy causes selective damage to so-called fast fibers.
- Such modifications condition the measured average values of speed of propagation of the myoelectric signal.
- muscle fibers are only activated if the stress is greater than a certain threshold at their neuromuscular junction.
- the fibers are grouped into functional units, the motor unit which groups together all of the fibers innervated by the same motor neuron.
- the motor unit action potential is equal to the sum of the elementary muscular action potentials of each of its component fibers.
- the myoelectric signal received at the electrode results from the spatial and temporal summation of the signals of all the motor units recruited.
- Signal measurement is affected by the anatomical and functional properties of the muscle studied and by the control patterns of the central or peripheral nervous system.
- the complexity of the electromyographic signal has given rise to multiple measurement and processing protocols, without any protocol or any attempt at modeling allowing, until now, a reliable and reproducible analysis of the characteristics of the signal allowing an understanding and an identification of the physiological reality of the muscle.
- Another method is based on an indirect evaluation from spectral parameters, such as the average frequency or the median frequency, supposed to be linearly correlated to the conduction speed.
- spectral parameters such as the average frequency or the median frequency
- Such a method is described in the article by Lindstrôm et al. published in the journal Electromyography, vol. 10, pages 341 to 356, 1970 or in the article by Stulen FB and De Luca of the review IEEE Trans. Biomed. Eng. , flight. 28, pages 515 to 523, 1981.
- Experimental studies have shown the limits of this type of relationship, the spectral parameters being dependent on several factors other than the speed of propagation of the muscular action potential.
- the anisotropy of the muscle and tissue properties located between the signal source and the detection zone leads to variations in the spectral content of the signal and in the estimation of the conduction speed.
- the electrodes are arranged in groups for each of which the signals transmitted by the electrodes are, after amplification, combined by weighted summation into a single signal, equivalent to the signal supplied by a spatial filter whose characteristics are determined by the factors of weighting of the electrode signals and by the geometric distribution of the electrodes in the group. It has been shown that one of the most interesting arrangements consists in forming groups of five electrodes arranged in a cross with a central electrode and four peripheral electrodes and in applying to the electrode signals a weighting factor equal to 4 (or - 4). for the central electrode and at - 1 (or at + 1) for each peripheral electrode, which corresponds to a double spatial differentiation of the surface distribution of potential in two orthogonal directions, i.e.
- the number of "Laplacian" groups of electrodes is relatively high, for example 16 or more, or even 64, and the neighboring groups have electrodes in common to reduce the total number electrodes and size.
- the signals picked up by the electrodes are preamplified, applied to a bandpass filter, then amplified and digitized to be recorded in an information processing system equipped with software performing high-pass filtering, spatial filtering of the type indicated above and an evaluation of the resulting signals. It has also been proposed to use in these systems larger groups of electrodes, comprising for example 9 electrodes arranged in a square matrix, in order to perform isotropic spatial filtering which is more efficient in terms of the spatial resolution of the detection.
- the large number of electrodes (32 in some systems, 128 in others) is, on the one hand, an advantage because it allows all of the electrodes to be placed on a muscular zone without seeking great precision , and then to select, by examining the spatially filtered signals, the electrode groups best placed with respect to the motor units examined.
- This large number of electrodes is also a drawback because of the surface occupied by all of the electrodes and the large number of amplifiers and high-pass or band-pass filters associated with the electrodes.
- the computer processing of the signals from the electrodes does not make it possible to have directly exploitable signals in real time and, in general, all the means of acquisition and processing of the signals are complex and can only be used by experienced specialists. Another consequence of this complexity is that, if these systems are of certain interest as as apparatus laboratory or research tools, they are not at all suited to routine use in hospitals.
- the object of the invention is in particular to overcome this drawback by proposing a non-invasive system of electromyographic measurements, which makes it possible to have information of a quality comparable to that which can be obtained with the aforementioned multielectrode systems, and which is simple and compact enough to be portable and usable by medical personnel who are not very specialized but of course trained in this technique, for example in a hospital environment for monitoring pathologies or the effects of a therapeutic treatment.
- the electromyographic measurement device with surface electrodes comprises at least one group of electrodes and means of spectral filtering and amplification with weighted summation carrying out spatial filtering of the signals transmitted by the electrodes, and is characterized in that that the aforementioned means of spectral filtering and amplification with weighted summation consist of circuits mounted with the electrodes in a housing of which one face carrying the electrodes forms a detection face, the device also comprising means for connecting this housing to supply means, amplification means and data processing means.
- the device according to the invention makes it possible to obtain in real time, at the output of the aforementioned box, signals which have been spatially filtered on site and which are directly exploitable, for example by viewing on a cathodic screen, unlike known multielectrode systems in which the spatially filtered signals are only available in deferred time at the output of the computer processing means.
- This device can comprise, depending on the applications for which it is intended, a single group of electrodes, or two or three groups of electrodes, or more, each group being associated with spectral filtering and spatial filtering circuits contained in the housing. cited above.
- the number of groups of electrodes remains small, so that the dimensions of the housing containing the electrodes and the associated spectral filtering and spatial filtering circuits remain as small as possible so that the detection face of this housing can be applied to a muscular area of reduced surface, not comprising tendon and innervation regions liable to disturb detection and measurement.
- the other elements of the device can be integrated in another case having dimensions sufficiently small to be easily transportable.
- the data processing system may be an independent portable microcomputer connectable to a box containing the supply circuits and an oscilloscope or other similar means for viewing the spatially filtered signals.
- the dimensions of the electrodes and the distances between electrodes are advantageously determined as a function of the characteristics of the muscle to which they will be applied, the diameters of the electrodes varying between 1 and 4 mm approximately, the distance between electrodes being preferably substantially equal to 2.5 times the diameter of an electrode.
- the ends of the electrodes intended to be applied to the skin are preferably sawtooth, in order to improve the quality of the contact with the skin and therefore the quality of the signals transmitted by the electrodes.
- the spatially filtered signals are themselves subjected to an additional differential amplification, making it possible to improve the quality of the resulting signals, either by verifying that the common mode has been completely eliminated, or by eliminating more completely the common mode present in the signals transmitted by the electrodes and due to the presence of non-propagated activities in the zone examined.
- means are provided for validating the location of the electrodes relative to an underlying muscular zone, these validation means comprising means for spectral analysis in real time of the spatially filtered signals, making it possible to determine the median frequencies or the average frequencies of these signals and compare them with each other to validate a measurement when the median frequency or the average frequency of the signal of a central group of electrodes is less than or substantially equal to the median frequencies or the average frequencies of the signals of the neighboring groups, respectively. Thanks to these characteristics, the device according to the invention is particularly well suited to the clinical monitoring of neuromuscular pathologies. It also applies to any area of muscle monitoring in which at least one surface electrode is used, for example in biomechanics, physiology and sports medicine.
- the invention allows clinical monitoring of neuromuscular function in response to short- or medium-term stresses to which the muscular system may be subject, for example fatigue, treatment, rehabilitation, hypokinesia.
- FIGS. 1a and 1b respectively represent the configuration of the detection face of a housing and the shape of the electrodes of the device according to the invention in an exemplary embodiment with three groups of electrodes;
- FIG. 2 represents an alternative embodiment of an electrode,
- FIG. 3 diagrammatically represents an electronic circuit board of the detection unit,
- FIG. 4 diagrammatically represents the processing chain for the captured signals,
- Figure 5 shows a visualization of muscle action potentials obtained using the device according to the invention.
- a set of electrodes and associated circuits for spectral filtering and spatial filtering is contained in a housing 1 of small dimensions, one face of which comprises a plate 2 of electrically insulating material on which appear from the ends of the electrodes E intended to be applied to the skin of a patient at the level of a muscular zone to be studied.
- the electrodes E are here eleven in number and are arranged in a matrix configuration in three rows comprising respectively three, five and three electrodes to form three groups L1, L2 and L3, each group comprising a central electrode E1, E2, E3 respectively and four electrodes located equidistant from the central electrode, these four electrodes being aligned two by two with the central electrode in perpendicular directions, the assembly forming a cross.
- the central group of electrodes L2 has two electrodes in common, respectively (E2, El), and (E2, E3), with each of the other two groups L1 and L3.
- An electrode E is shown diagrammatically in perspective in FIG. 1b, and comprises a cylindrical tube 3 connected to a support disc 4 at one end, this disc 4 being the detection end and appearing on the detection face 2 of the housing 1.
- L electrode E can be made of any electroconductive material and for example of gilded copper or in a gold-silver alloy -copper in the following respective proportions: 75%, 20% and 5%.
- Gold has excellent resistance to external agents (acidity, sweat, ...) and excellent safety compared to the skin and is stiffened by the addition of silver or any other electroconductive metal having the desired mechanical properties. Copper facilitates electrical transmission with the electronic circuit shown schematically in Figure 3.
- the cylindrical tube 3 of the electrode may have a diameter of 2 millimeters and the head 4 a diameter of 4 millimeters, the tube coming to be inserted directly into the electronic circuit.
- the diameter of the electrode heads can vary between approximately 1 and 4 millimeters, the distance between electrodes being between 2.5 and 10 millimeters approximately and preferably being substantially equal to 2.5 times the diameter of the electrode.
- the heads of the electrodes E have a diameter of 2 millimeters, the distance between the electrodes is 5 millimeters, the dimensions of the detection surface 2 are 3 cm ⁇ 2 cm, and the external dimensions of the housing 1 are approximately 6 cm x 4 cm x 2 cm.
- the head 4 of the electrode E has an application face on the skin which is not flat, but in "sawtooth" shape, in order to improve the quality of the contact between the electrode and the skin.
- the electrodes E are carried by a printed circuit board RI, for example made of glass fibers - epoxy coming to connect to an amplification circuit VI, the plate RI and the circuit VI being shown side by side in FIG. 3.
- a printed circuit board RI for example made of glass fibers - epoxy coming to connect to an amplification circuit VI, the plate RI and the circuit VI being shown side by side in FIG. 3.
- each electrode E is connected to amplification means 5 via a connector K and a high-pass filter 6 conventionally constituted by a circuit of the type RC. Filtering at 6 Hz is provided, to overcome the effects of polarization of the electrodes.
- the amplification means 5 comprise, for all of the electrodes E, three operational amplifiers 7 with high input impedance, each operational amplifier 7 being associated with a group L1, L2 or L3 respectively of electrodes so that the signals transmitted by the electrodes of this group are amplified with a weighting factor which is equal to + 4 (or - 4) for the central electrode and - 1 (or + 1) for each of the four peripheral electrodes.
- These circuits are made in CMOS-CMS technology or etched in the form of ASIC and the operational amplifiers 7 have a linear gain equal to 100 and a common mode rejection rate close to 100 dB.
- the on-site amplification of the signals transmitted by the electrodes makes it possible to increase the signal / noise ratio, the signals picked up having a low level, typically of the order of 50 ⁇ V at 1 rav.
- the housing 1 containing the aforementioned electrodes and circuits has three output channels including each transmits the output signal from an operational amplifier 7, two input channels for supplying these amplifiers and one channel connected to a reference electrical conductor.
- a non-magnetic shielding of the housing is obtained by coating the internal faces of the housing with a copper foil or the like, connected to the reference electrical conductor.
- the detection unit 1 is connected to a power supply unit 9 which further transmits the output signals from the unit 1 to an isolated amplifier stage 10 whose output is connected to an oscilloscope 11 or other analog signal display means, and to a device 12 for acquiring and processing digital data.
- the connections are made using shielded cables of the BNC type.
- the device 12 can be a microcomputer of the PC type or the like with a video screen for viewing the signals.
- the device according to the invention is used in the following way:
- the detection face of the housing 1 is applied directly to the skin, without the addition of contact gel, in a muscle area to be examined.
- the spatially filtered signals of the three groups of electrodes are displayed on the screen of the oscilloscope 11. A visualization of these three signals S1, S2 and S3 is shown in FIG.
- a recording of the signals for a period of a few seconds makes it possible to obtain a distribution of the speeds of propagation of the detectable muscular action potentials brought into play during the effort.
- the recording is extended over a necessarily longer period.
- the invention has provided a certain number of means making it possible to verify this location and this orientation.
- the real-time visualization of the signals on the oscilloscope screen makes it possible to verify an approximate location and the orientation of the groups of electrodes on the muscle fibers. For this, we check the direction of propagation of the action potentials (validation of the location of the electrodes in relation to the neuromuscular junctions) and the amplitude of the action potentials (validation of the alignment of the electrodes according to the muscle fibers).
- a frequency analysis of the spatially filtered signals makes it possible to validate the location of the electrodes, to accept or reject the measurements made with these electrodes.
- the average or median frequencies of the signals transmitted by the electrodes or those of the spatially filtered signals vary according to the location of the electrodes, in the same direction as the estimates of the propagation speeds (the mean frequency of the signal being the statistical mean of the spectral power density of the signal, its median frequency being that which divides the surface of the spectrum into two equal parts).
- the method for validating the location of the electrodes therefore consists, according to the invention, in determining the average or median frequencies of the spatially filtered signals of the three groups of electrodes, to compare them and to validate the localization when the average or median frequency of the signal of the central group is lower or equal to the average or median frequencies of the signals of the two other groups of electrodes.
- the average frequencies of the signals can be calculated from the Fourier transforms of these signals.
- the invention is not limited to the exemplary embodiments which have been described and shown. It is in particular possible to use more than three groups of electrodes in the device according to the invention, or else a single group of electrodes for the detection of muscular activity, or two groups of electrodes for the determination of propagation of muscle action potentials.
- the groups of electrodes can be supplemented to each comprise nine electrodes with a square matrix arrangement (analogous to that which can be seen in FIG. 1a as regards the central electrode E2, surrounded by eight other electrodes).
- the weighting coefficients of the electrode signals can then be - 12 (or + 12) for a central electrode, + 2 (or - 2) for the four electrodes closest to the central electrode, and + 1 (or - 1) for the other four electrodes (as described in the article published in "IEEE Transactions and Biomedical Engineering", Vol. 44, No. 7, July 1997, by C. Disselhorst-Klug, J. Silny and G. Rau).
- the invention can also be used in an NMR (Nuclear Magnetic Resonance) type tunnel in order to quantify the parameters of the electromyography: the variation of the electromyographic parameters, speed of propagation or spectral analysis of the muscle action potential, is then correlated. to the kinetics of metabolic parameters, such as the concentration of hydrogen ions or of phosphate-bound ions (adenosine di or tri-phosphate, inorganic phosphate, phosphocreatine, ...), provided by NMR spectroscopy. It is thus possible to study the influence of metabolic parameters on electromyographic parameters, and to deduce correlations with physiological measurements relating to certain pathologies, for example during muscle fatigue.
- NMR Nuclear Magnetic Resonance
- this measurement system can be used in place of any system of surface electrodes, whether they are floating or dry, in particular in the fields of biomechanics and ergonomics, the dimensions of the electrodes and the number of Laplacian signals measured then being adapted as a function of the desired use, generally using one to three groups of electrodes.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98962540A EP1041928A1 (en) | 1997-12-22 | 1998-12-22 | Non-invasive device for electromyographic measurements |
JP2000525030A JP2001526074A (en) | 1997-12-22 | 1998-12-22 | Non-invasive device for electromyographic measurements |
CA002312879A CA2312879A1 (en) | 1997-12-22 | 1998-12-22 | Non-invasive device for electromyographic measurements |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR97/16272 | 1997-12-22 | ||
FR9716272A FR2772588B1 (en) | 1997-12-22 | 1997-12-22 | NON-INVASIVE DEVICE FOR ELECTROMYOGRAPHIC MEASUREMENTS, PROCESS FOR VALIDATION OF THESE MEASUREMENTS AND USE OF SUCH A DEVICE |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999032032A1 true WO1999032032A1 (en) | 1999-07-01 |
Family
ID=9514934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1998/002837 WO1999032032A1 (en) | 1997-12-22 | 1998-12-22 | Non-invasive device for electromyographic measurements |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1041928A1 (en) |
JP (1) | JP2001526074A (en) |
CA (1) | CA2312879A1 (en) |
FR (1) | FR2772588B1 (en) |
WO (1) | WO1999032032A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6901286B1 (en) * | 1999-07-07 | 2005-05-31 | Universite De Montreal | Method and system for producing a higher quality electromyographic signal from an electrode array |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE473678T1 (en) * | 2004-02-27 | 2010-07-15 | Koninkl Philips Electronics Nv | PORTABLE WIRELESS DEVICE FOR MONITORING, ANALYZING AND COMMUNICATING PHYSIOLOGICAL STATUS |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3905355A (en) * | 1973-12-06 | 1975-09-16 | Joseph Brudny | System for the measurement, display and instrumental conditioning of electromyographic signals |
EP0025222A2 (en) * | 1979-09-10 | 1981-03-18 | The Regents Of The University Of California | Apparatus for monitoring neuromuscular transmission |
WO1991001683A1 (en) * | 1989-07-31 | 1991-02-21 | Biolin Ab | A method and an apparatus in electromyography |
US5212476A (en) * | 1990-09-28 | 1993-05-18 | Maloney Sean R | Wireless intraoral controller disposed in oral cavity with electrodes to sense E.M.G. signals produced by contraction of the tongue |
US5349963A (en) * | 1993-08-06 | 1994-09-27 | Sanhill Oy | Method and apparatus for measuring muscle fatigue |
WO1996029929A1 (en) * | 1995-03-29 | 1996-10-03 | The University Of Queensland | Diagnosis of neuromuscular dysfunction |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0436809Y2 (en) * | 1986-12-24 | 1992-08-31 |
-
1997
- 1997-12-22 FR FR9716272A patent/FR2772588B1/en not_active Expired - Fee Related
-
1998
- 1998-12-22 CA CA002312879A patent/CA2312879A1/en not_active Abandoned
- 1998-12-22 WO PCT/FR1998/002837 patent/WO1999032032A1/en not_active Application Discontinuation
- 1998-12-22 JP JP2000525030A patent/JP2001526074A/en active Pending
- 1998-12-22 EP EP98962540A patent/EP1041928A1/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3905355A (en) * | 1973-12-06 | 1975-09-16 | Joseph Brudny | System for the measurement, display and instrumental conditioning of electromyographic signals |
EP0025222A2 (en) * | 1979-09-10 | 1981-03-18 | The Regents Of The University Of California | Apparatus for monitoring neuromuscular transmission |
WO1991001683A1 (en) * | 1989-07-31 | 1991-02-21 | Biolin Ab | A method and an apparatus in electromyography |
US5212476A (en) * | 1990-09-28 | 1993-05-18 | Maloney Sean R | Wireless intraoral controller disposed in oral cavity with electrodes to sense E.M.G. signals produced by contraction of the tongue |
US5349963A (en) * | 1993-08-06 | 1994-09-27 | Sanhill Oy | Method and apparatus for measuring muscle fatigue |
WO1996029929A1 (en) * | 1995-03-29 | 1996-10-03 | The University Of Queensland | Diagnosis of neuromuscular dysfunction |
Non-Patent Citations (3)
Title |
---|
LINDSTRÖM ET AL., ELECTROMYOGRAPHY, vol. 10, 1970, pages 341 - 356 |
REUCHER H. ET AL., IEEE TRANS. BIOMED., vol. 34, 1987, ENG., pages 98 - 113 |
STULEN F.B. ET DE LUCA, IEEE TRANS. BIOMED., vol. 28, 1981, ENG., pages 515 - 523 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6901286B1 (en) * | 1999-07-07 | 2005-05-31 | Universite De Montreal | Method and system for producing a higher quality electromyographic signal from an electrode array |
Also Published As
Publication number | Publication date |
---|---|
FR2772588B1 (en) | 2000-02-18 |
EP1041928A1 (en) | 2000-10-11 |
FR2772588A1 (en) | 1999-06-25 |
JP2001526074A (en) | 2001-12-18 |
CA2312879A1 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Picton et al. | The recording and analysis of event-related potentials | |
Mechler et al. | Three-dimensional localization of neurons in cortical tetrode recordings | |
Trejo et al. | Attentional modulation of the mismatch negativity elicited by frequency differences between binaurally presented tone bursts | |
Bronzino et al. | Principles of electroencephalography | |
US10987015B2 (en) | Dry electrodes for electroencephalography | |
EP1898783B1 (en) | Electrophysiological analysis system and method | |
Obeid et al. | Two multichannel integrated circuits for neural recording and signal processing | |
Koka et al. | Improvement of spatial selectivity and decrease of mutual information of tri-polar concentric ring electrodes | |
US20130296715A1 (en) | Instrument and method for high-speed perfusion imaging | |
EP2152157B1 (en) | Method, device and system for reducing artifacts affecting electrophysiological signals and caused by electromagnetic fields | |
Zhang et al. | Non-invasive detection of low-level muscle fatigue using surface EMG with wavelet decomposition | |
Kamerer et al. | A model of auditory brainstem response wave I morphology | |
WO1999032032A1 (en) | Non-invasive device for electromyographic measurements | |
EP0681447B1 (en) | Device for the determination of physiological information and corresponding use | |
EP1637075A1 (en) | Method and device for evaluating pain in a living being | |
EP4031005B1 (en) | System for determining an emotion of a user | |
EP2285273A1 (en) | Non-invasive method and system for detecting and evaluating neural electrophysiological activity | |
CN215191453U (en) | All-in-one data acquisition device and system based on frequency division multiplexing | |
WO2022064425A1 (en) | Electrodermal apparatus | |
FR2970801A1 (en) | METHOD FOR DETERMINING TREATMENT EFFICIENCY AND ASSOCIATED IMAGE PROCESSING SYSTEM | |
Burden | Electromyography | |
Suma et al. | Stress Level Detection Using Electroencephalography Signals | |
Rossel et al. | New electrode layout for internal selectivity of nerves | |
Oveisi et al. | Assessing the Validity and Reliability of HD-DOT TD-fNIRS Resting-State Measurements in Rapid Succession Data Collection Settings | |
Arthur et al. | Neural Correlates of Complex Tone Processing and Hemispheric Asymmetry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998962540 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2312879 Country of ref document: CA Ref country code: CA Ref document number: 2312879 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1998962540 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998962540 Country of ref document: EP |